Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Guangzhou Jinqirui Biotechnology

Request full access

Precision molecular diagnostics and NGS solutions

Guangzhou, ChinaFounded 2016

About Guangzhou Jinqirui Biotechnology

Guangzhou Jinqirui Biotechnology Co., Ltd., also known as KingCreate Biotechnology, was founded in 2016 and is headquartered in Guangzhou, China. The company specializes in the research, development, production, and sales of in-vitro diagnostic products for precision medicine. It aims to provide localized precision molecular diagnostic solutions for various medical institutions.

The firm has developed proprietary technologies in multiplex PCR, ultra-multiplex targeted sequencing (tNGS), and metagenomics (mNGS), which have applications in oncology and infectious diseases. Its product portfolio includes genetic sequencers like the KM MiniSeqDx-CN system, automated sample processing systems, nucleic acid extractors, and various testing kits. Notably, its respiratory pathogen and HPV testing kits received CE certification in 2022, and the company obtained NMPA (National Medical Products Administration) registration for its gene sequencer in 2020 and a multi-gene tumor test kit in 2022. This makes it one of the few domestic companies in China offering a complete solution for tumor companion diagnostics, including the sequencer, clinical applications, and software.

The company serves the diagnostic equipment and biotechnology industries, with a focus on life sciences and oncology. Its business model involves providing these integrated diagnostic systems and related reagents to medical facilities. KingCreate Biotechnology is a privately held, venture capital-backed company. It has completed multiple funding rounds, including a Series A in 2019, Series B in 2020, and a Series C in August 2023. Key investors include Legend Capital, E Fund Management, Aurora Private Equity, and China Development Bank Capital.

Source: Dealroom company data

Guangzhou Jinqirui Biotechnology in the Guangzhou ecosystem

Live from Dealroom

The Guangzhou Jinqirui Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later2 investors entered at this stage

  • Chenhui Venture Partners
  • Shengjing Jiacheng
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Guangzhou HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Guangzhou Jinqirui Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Guangzhou Jinqirui Biotechnology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.